Smad7是结肠直肠癌中免疫细胞死亡的负调节者
Claudia Maresca1, Eleonora Franzè1, Federica Laudisi1
1Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Oncoimmunology
|April 11, 2025
概括
在结直肠癌细胞中向抑制Smad7可触发免疫细胞死亡 (ICD),减少瘤生长并增强抗癌免疫反应. 缺乏Smad7可促进卡尔雷蒂库林暴露和免疫细胞激活,提供一种新的免疫疗法策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 细胞内膜网膜 (ER) 的压力会诱导癌细胞暴露于calreticulin,从而启动一种称为免疫细胞死亡 (ICD) 的抗癌免疫反应.
- 在结直肠癌 (CRC) 细胞中Smad7的高表达可能会抑制ER压力并限制ICD.
- 针对Smad7可能会增强抗癌免疫力.
研究的目的:
- 为了研究抑制CRC细胞中的Smad7是否会促进抗癌免疫反应.
- 为了确定Smad7缺乏是否会在结直肠癌中触发ICD.
主要方法:
- 在人类 (HCT116,DLD1) 和小鼠 (CT26) 的CRC细胞系中,使用反感性寡核酸的Smad7被下调.
- 评估了卡尔雷蒂库林暴露,ATP和HMGB1分泌以及树突细胞激活.
- 在小鼠模型中评估了瘤生长,免疫细胞透 (CD8 +,CD4 +) 和保护性免疫力.
主要成果:
- 降低Smad7的调节诱导了calreticulin转移到血,这种效应被ER压力抑制剂阻断.
- 缺乏Smad7的细胞分泌了增加的ATP和HMGB1,激活了共同培养的树突细胞.
- 患有Smad7缺陷瘤的小鼠显示瘤生长减少,CD8+ T细胞透增加,以及对野生类型瘤挑战的保护.
结论:
- 在结直肠癌细胞中,Smad7缺乏引发ICD,通过诱导ER压力和calreticulin暴露.
- 抑制Smad7通过增强的抗癌免疫反应来减少瘤的发展和生长.
- Smad7 抑制剂代表了一种潜在的新型治疗策略,用于在癌症免疫治疗中诱导 ICD.
相关概念视频
01:45Positive Regulator Molecules
105.6K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.6K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K